IL2 and head and neck squamous cell carcinoma: In summary, adenoviruses armed with IL-2 and TNFα are able to significantly improve therapeutic outcome in ICI sensitive, primary resistant and acquired resistant models of HNSCC, likely through immunogenic viral oncolysis and induction of a cytolytic immune response associated with tertiary lymphoid structure formation.